Silencing of argininosuccinate lyase inhibits colorectal cancer formation

Hau Lun Huang, Wei Ching Chen, Hui Ping Hsu, Chien Yu Cho, Yu Hsuan Hung, Chih Yang Wang, Ming Derg Lai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Arginine and nitric oxide (NO) are important mediators of tumorigenesis in various types of cancer. Dysregulation of NO content by argininosuccinate lyase (ASL) has been previously demonstrated to inhibit the proliferation of liver and breast cancer cells. However, the function of ASL in colon cancer is not well defined. The present study aimed to determine the effect of ASL on colon cancer. Western blot analysis indicated that ASL expression was induced by endoplasmic reticulum stress in HCT116 and SW480 colon cancer cells. Additionally, the expression of ASL in colon cancer tissues was enhanced compared with that in the adjacent normal tissues, and the patients with colon cancer with higher ASL expression exhibited poorer survival rates. Transfection of ASL-targeting short hairpin RNA (shRNA) into HCT116 cells inhibited cell proliferation and decreased anchorage-independent growth in a soft agar assay. In addition, when injected subcutaneously into NOD/SCID mice, stable transfectant ASL-downregulated HCT116 cells exhibited decreased in vivo tumorigenic ability. Flow cytometric analysis of cell cycle progression indicated that ASL-targeting shRNA induced G2/M arrest, and western blot analysis showed that the inhibition of ASL was accompanied by cyclin A2 degradation. Furthermore, ASL-targeting shRNA resulted in increased autophagosomes and decreased NO levels. Inhibition of NO by the NO synthase inhibitor L-NMMA significantly reduced cell proliferation and colony formation. In summary, the results of the present study indicated that ASL-targeting shRNA-induced growth inhibition is associated with decreased cyclin A2 expression and NO content in colon cancer.

Original languageEnglish
Pages (from-to)163-170
Number of pages8
JournalOncology Reports
Volume37
Issue number1
DOIs
Publication statusPublished - 2017 Jan

Fingerprint

Argininosuccinate Lyase
Colorectal Neoplasms
Colonic Neoplasms
Nitric Oxide
Small Interfering RNA
Cyclin A2
HCT116 Cells
Western Blotting
Cell Proliferation
omega-N-Methylarginine
Inbred NOD Mouse
Endoplasmic Reticulum Stress
SCID Mice
Liver Neoplasms
Growth
Nitric Oxide Synthase

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Huang, Hau Lun ; Chen, Wei Ching ; Hsu, Hui Ping ; Cho, Chien Yu ; Hung, Yu Hsuan ; Wang, Chih Yang ; Lai, Ming Derg. / Silencing of argininosuccinate lyase inhibits colorectal cancer formation. In: Oncology Reports. 2017 ; Vol. 37, No. 1. pp. 163-170.
@article{7b07df6f1f28441bade77ca06ee7be36,
title = "Silencing of argininosuccinate lyase inhibits colorectal cancer formation",
abstract = "Arginine and nitric oxide (NO) are important mediators of tumorigenesis in various types of cancer. Dysregulation of NO content by argininosuccinate lyase (ASL) has been previously demonstrated to inhibit the proliferation of liver and breast cancer cells. However, the function of ASL in colon cancer is not well defined. The present study aimed to determine the effect of ASL on colon cancer. Western blot analysis indicated that ASL expression was induced by endoplasmic reticulum stress in HCT116 and SW480 colon cancer cells. Additionally, the expression of ASL in colon cancer tissues was enhanced compared with that in the adjacent normal tissues, and the patients with colon cancer with higher ASL expression exhibited poorer survival rates. Transfection of ASL-targeting short hairpin RNA (shRNA) into HCT116 cells inhibited cell proliferation and decreased anchorage-independent growth in a soft agar assay. In addition, when injected subcutaneously into NOD/SCID mice, stable transfectant ASL-downregulated HCT116 cells exhibited decreased in vivo tumorigenic ability. Flow cytometric analysis of cell cycle progression indicated that ASL-targeting shRNA induced G2/M arrest, and western blot analysis showed that the inhibition of ASL was accompanied by cyclin A2 degradation. Furthermore, ASL-targeting shRNA resulted in increased autophagosomes and decreased NO levels. Inhibition of NO by the NO synthase inhibitor L-NMMA significantly reduced cell proliferation and colony formation. In summary, the results of the present study indicated that ASL-targeting shRNA-induced growth inhibition is associated with decreased cyclin A2 expression and NO content in colon cancer.",
author = "Huang, {Hau Lun} and Chen, {Wei Ching} and Hsu, {Hui Ping} and Cho, {Chien Yu} and Hung, {Yu Hsuan} and Wang, {Chih Yang} and Lai, {Ming Derg}",
year = "2017",
month = "1",
doi = "10.3892/or.2016.5221",
language = "English",
volume = "37",
pages = "163--170",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "1",

}

Silencing of argininosuccinate lyase inhibits colorectal cancer formation. / Huang, Hau Lun; Chen, Wei Ching; Hsu, Hui Ping; Cho, Chien Yu; Hung, Yu Hsuan; Wang, Chih Yang; Lai, Ming Derg.

In: Oncology Reports, Vol. 37, No. 1, 01.2017, p. 163-170.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Silencing of argininosuccinate lyase inhibits colorectal cancer formation

AU - Huang, Hau Lun

AU - Chen, Wei Ching

AU - Hsu, Hui Ping

AU - Cho, Chien Yu

AU - Hung, Yu Hsuan

AU - Wang, Chih Yang

AU - Lai, Ming Derg

PY - 2017/1

Y1 - 2017/1

N2 - Arginine and nitric oxide (NO) are important mediators of tumorigenesis in various types of cancer. Dysregulation of NO content by argininosuccinate lyase (ASL) has been previously demonstrated to inhibit the proliferation of liver and breast cancer cells. However, the function of ASL in colon cancer is not well defined. The present study aimed to determine the effect of ASL on colon cancer. Western blot analysis indicated that ASL expression was induced by endoplasmic reticulum stress in HCT116 and SW480 colon cancer cells. Additionally, the expression of ASL in colon cancer tissues was enhanced compared with that in the adjacent normal tissues, and the patients with colon cancer with higher ASL expression exhibited poorer survival rates. Transfection of ASL-targeting short hairpin RNA (shRNA) into HCT116 cells inhibited cell proliferation and decreased anchorage-independent growth in a soft agar assay. In addition, when injected subcutaneously into NOD/SCID mice, stable transfectant ASL-downregulated HCT116 cells exhibited decreased in vivo tumorigenic ability. Flow cytometric analysis of cell cycle progression indicated that ASL-targeting shRNA induced G2/M arrest, and western blot analysis showed that the inhibition of ASL was accompanied by cyclin A2 degradation. Furthermore, ASL-targeting shRNA resulted in increased autophagosomes and decreased NO levels. Inhibition of NO by the NO synthase inhibitor L-NMMA significantly reduced cell proliferation and colony formation. In summary, the results of the present study indicated that ASL-targeting shRNA-induced growth inhibition is associated with decreased cyclin A2 expression and NO content in colon cancer.

AB - Arginine and nitric oxide (NO) are important mediators of tumorigenesis in various types of cancer. Dysregulation of NO content by argininosuccinate lyase (ASL) has been previously demonstrated to inhibit the proliferation of liver and breast cancer cells. However, the function of ASL in colon cancer is not well defined. The present study aimed to determine the effect of ASL on colon cancer. Western blot analysis indicated that ASL expression was induced by endoplasmic reticulum stress in HCT116 and SW480 colon cancer cells. Additionally, the expression of ASL in colon cancer tissues was enhanced compared with that in the adjacent normal tissues, and the patients with colon cancer with higher ASL expression exhibited poorer survival rates. Transfection of ASL-targeting short hairpin RNA (shRNA) into HCT116 cells inhibited cell proliferation and decreased anchorage-independent growth in a soft agar assay. In addition, when injected subcutaneously into NOD/SCID mice, stable transfectant ASL-downregulated HCT116 cells exhibited decreased in vivo tumorigenic ability. Flow cytometric analysis of cell cycle progression indicated that ASL-targeting shRNA induced G2/M arrest, and western blot analysis showed that the inhibition of ASL was accompanied by cyclin A2 degradation. Furthermore, ASL-targeting shRNA resulted in increased autophagosomes and decreased NO levels. Inhibition of NO by the NO synthase inhibitor L-NMMA significantly reduced cell proliferation and colony formation. In summary, the results of the present study indicated that ASL-targeting shRNA-induced growth inhibition is associated with decreased cyclin A2 expression and NO content in colon cancer.

UR - http://www.scopus.com/inward/record.url?scp=85006470358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006470358&partnerID=8YFLogxK

U2 - 10.3892/or.2016.5221

DO - 10.3892/or.2016.5221

M3 - Article

C2 - 27840980

AN - SCOPUS:85006470358

VL - 37

SP - 163

EP - 170

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 1

ER -